Tango Therapeutics, Inc. (TNGX) is a publicly traded Healthcare sector company. As of May 21, 2026, TNGX trades at $20.87 with a market cap of $2.98B and a P/E ratio of -24.47. TNGX moved +3.69% today. Year to date, TNGX is +136.59%; over the trailing twelve months it is +918.36%. Its 52-week range spans $1.03 to $28.41. Analyst consensus is strong buy with an average price target of $30.70. Rallies surfaces TNGX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Tango Therapeutics, Inc. (TNGX) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. TNGX moved +3.69% today. Analyst consensus is strong buy.
| Metric | Value |
|---|---|
| Price | $20.87 |
| Market Cap | $2.98B |
| P/E Ratio | -24.47 |
| EPS | $-0.87 |
| Dividend Yield | 0.00% |
| 52-Week High | $28.41 |
| 52-Week Low | $1.03 |
| Volume | 45 |
| Avg Volume | 0 |
| Revenue (TTM) | $62.38M |
| Net Income | $-101.59M |
| Gross Margin | 0.00% |
10 analysts cover TNGX: 0 strong buy, 8 buy, 2 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $30.70.